Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
12/2000
12/05/2000US6156345 Crosslinkable macromers bearing initiator groups
12/05/2000US6156343 Coating layer comprising water-insoluble polymer and at least one selected from water-soluble polymer and an enteric polymer and a core comprising mixture of a drug and a water-soluble polymer or a solid dispersion of a drug
12/05/2000US6156342 Controlled release oral dosage form
12/05/2000US6156341 Stability; oxidation resistance
12/05/2000US6156340 Orally administrable time release drug containing products
12/05/2000US6156339 Forming solution or suspension in solvent of water soluble or water dispersible carrier, filler and pharmaceutically active substance with unacceptable taste in association with lipid; forming discrete units; removing solvent to form unit dosage
12/05/2000US6156338 Method for preparing compositions for transferring nucleic acids
12/05/2000US6156337 Combining dry, liposome-forming lipids with a physiologically compatible solution of a biopolymeric substance functional in humans; mixing with polar-protic solvent; lyophilizing to dry product which upon hydration forms liposomes
12/05/2000US6156336 Die casting or extruding polymers or polymer containing preparations into elongated article having active ingredient-containing core and inert enveloping surface to a contour of layered article; converting into single disks
12/05/2000US6156335 Tolerated, stable, effective, prevents the crystallisation of active ingredient in the matrix, ensures adequate and extended levels of the active ingredient in blood, and has tack and adhesive properties
12/05/2000US6156332 Method and composition for masking mineral taste
12/05/2000US6156330 Having a uniform and fine particle size and comprising microsporidian spores whose major cell wall substance is chitin; used in medicine/medical treatment, perfumes, cosmetics, adhesive/paints, varnishes
12/05/2000US6156323 Tricot-like pouch for the delivery of topical drugs and cosmetics
12/05/2000US6156305 Implanted tumor cells for the prevention and treatment of cancer
12/05/2000US6156294 Composition and method for treatment of otitis media
12/05/2000US6156293 Moistening preparation
12/05/2000US6156292 Extremely small bubbles, or ?microbubbles,? comprised of octafluoropropane, dodecafluoropentane, or decafluorobutane.
12/05/2000US6155259 Barrier device for contraception and prevention of sexually transmitted diseases
12/05/2000CA2193203C Polymer microparticles for drug delivery
12/05/2000CA2184365C Concentrated acetaminophen solution compositions
12/05/2000CA2184361C Solid dose forms containing bismuth
12/05/2000CA2181985C Modified-release metronidazole compositions and methods for making and using same
12/05/2000CA2135179C Pharmaceutical compositions of alkylsulphonamides 5ht1 agonists for rectal administration
12/05/2000CA2110914C Solubility parameter based drug delivery system and method for altering drug saturation concentration
12/05/2000CA2036089C Prolonged release microcapsules
12/04/2000CA2311112A1 Trovafloxacin oral suspensions
12/03/2000CA2281430A1 Skin care compositions and their use in healing injured skin
12/01/2000CA2310272A1 Transdermal estrogen agonist-antagonist therapy
11/2000
11/30/2000WO2000071734A1 Starch granules containing a recombinant polypeptide of interest, method for obtaining same and uses
11/30/2000WO2000071558A1 Orally active a1 adenosine receptor agonists
11/30/2000WO2000071424A1 Method and apparatus for distributing powder
11/30/2000WO2000071419A1 Method and apparatus for loading a container with a product
11/30/2000WO2000071194A1 Method and apparatus for treating a patient
11/30/2000WO2000071180A1 Bioadhesive hydrogels with functionalized degradable crosslinks
11/30/2000WO2000071172A1 Site specific binding system, nuclear imaging compositions and methods
11/30/2000WO2000071163A1 Emulsion vehicle for poorly soluble drugs
11/30/2000WO2000071154A2 Stability, biocompatibility optimized adjuvant (sba) for enhancing humoral and cellular immune response
11/30/2000WO2000071153A2 Medicament for localised application, containing fibrinogen, thrombin, transglutaminases and proteinase inhibitors
11/30/2000WO2000071146A2 Glutathione reductase for therapy and prophylaxis of aids
11/30/2000WO2000071137A1 Electrolyte gels for maintaining hydration and rehydration
11/30/2000WO2000071133A1 Transdermal device for the application of testosterone or one of the derivatives thereof
11/30/2000WO2000071125A2 Pharmaceutical preparation containing the active substance diamorphine and its utilization in a method for treating opiate addiction
11/30/2000WO2000071121A1 Microgranules insoluble in gastric fluid, method for obtaining same and pharmaceutical preparations
11/30/2000WO2000071117A1 Immediate release medicinal compositions for oral use
11/30/2000WO2000071110A1 Pharmaceutical compositions for oral administration of phloroglucinol and preparation thereof
11/30/2000WO2000071108A2 Methods for treatment of asthma using s-oxybutynin
11/30/2000WO2000071100A1 Device and method for increasing the transdermal permeation of medicaments
11/30/2000WO2000071099A1 Multiparticulate controlled release selective serotonin reuptake inhibitor formulations
11/30/2000WO2000071098A1 A pharmaceutical composition containing an active agent that is maintained in solid amorphous form and method of making the same
11/30/2000WO2000071097A1 Composition containing ascorbic acid salt
11/30/2000WO2000071096A2 Methods and compositions for non-viral gene therapy for treatment of hyperproliferative diseases
11/30/2000WO2000071095A2 Release of poorly soluble agents
11/30/2000WO2000071088A1 After shave composition containing aluminum chlorohydrate
11/30/2000WO2000071079A2 Protein stabilized pharmacologically active agents, methods for the preparation thereof and methods for the use thereof
11/30/2000WO2000071077A2 Adjuvant which is optimized with regard to stability and biocompatibility (sba) and which is provided for increasing the humoral and cellular immune response
11/30/2000WO2000070949A1 Method for using soluble curcumin to inhibit phosphorylase kinase in inflammatory diseases
11/30/2000WO2000054745A3 Devices and methods for pain management
11/30/2000WO2000042993A3 Nonaqueous solutions and suspensions of macromolecules for pulmonary delivery
11/30/2000WO2000042989A3 Novel hydrogel isolated cochleate formulations, process of preparation and their use for the delivery of biologically relevant molecules
11/30/2000WO2000042986A3 Artificial lacrimal fluid in gel form
11/30/2000WO2000041694A3 Compositions having improved stability
11/30/2000WO2000041693A3 Compositions having improved delivery of actives
11/30/2000WO2000041692A3 Compositions having improved stability
11/30/2000WO2000041546A3 Novel exendin agonist formulations and methods of administration thereof
11/30/2000WO2000040269A3 Pharmaceutical compositions for treatment of diseased tissues
11/30/2000WO2000035434A3 Compositions and methods for the treatment of anorectal disorders
11/30/2000WO2000033814A3 Method for administering agents to the central nervous system
11/30/2000WO2000028019A3 Antisense oligomer
11/30/2000WO2000027363A9 Aerosols comprising nanoparticle drugs
11/30/2000WO2000025829A3 Radiodense compositions
11/30/2000WO2000024391A3 Conductance of improperly folded proteins through the secretory pathway
11/30/2000WO2000010554A3 Methods and compositions employing optically pure s(+) vigabatrin
11/30/2000DE19925184A1 Kontinuierliches Verfahren zur Herstellung von morphologisch einheitlichen Mikro- und Nanopartikeln mittels Mikromischer sowie nach diesem Verfahren hergestellte Partikel A continuous process for the production of morphologically uniform micro- and nanoparticles by means of mixer, as well as micro particles produced by this method
11/30/2000DE19924643A1 Protein-charged microparticles preparation,useful in e.g. diagnostic assays, comprises heating suspension of microparticles and protein material, then irradiating with ultraviolet light
11/30/2000DE19924277A1 Zubereitungen von Emulsionstyp W/O mit erhöhtem Wassergehalt mit einem Gehalt an mittelpolaren Lipiden und Siliconemulgatoren und gegebenenfalls kationischen Polymeren Preparations of emulsion W / O type with increased water content with a content of medium-polar lipids and silicone emulsifiers and optionally cationic polymers
11/30/2000DE19923551A1 Pharmazeutisches Präparat mit dem Wirkstoff Diamorphin und seine Verwendung in einem Verfahren zur Behandlung der Opiatsucht A pharmaceutical preparation containing the active substance diamorphine and its use in a method for the treatment of opiate addiction
11/30/2000DE10016771A1 Nutritional supplements containing flavonoid and catechin derivatives
11/30/2000CA2698347A1 Multiparticulate controlled release selective serotonin reuptake inhibitor formulations
11/30/2000CA2374416A1 Starch granules containing a recombinant polypeptide of interest, method for obtaining same and uses
11/30/2000CA2374296A1 Bioadhesive hydrogels with functionalized degradable crosslinks
11/30/2000CA2374051A1 Release of poorly soluble agents
11/30/2000CA2373994A1 Emulsion vehicle for poorly soluble drugs
11/30/2000CA2373783A1 Method and apparatus for loading a container with a product
11/30/2000CA2373755A1 Method and apparatus for treating a patient
11/30/2000CA2373239A1 Stability, biocompatibility optimized adjuvant (sba) for enhancing humoral and cellular immune response
11/30/2000CA2371923A1 Methods for treatment of asthma using s-oxybutynin
11/29/2000EP1055424A2 Composition of W/O emulsion type with high water content containing medium-polarity lipids and silicone emulsifiers and optionally cationic polymers
11/29/2000EP1054998A1 Transglutaminase linkage of agents to tissue
11/29/2000EP1054901A2 Lipopeptides containing an interferon fragment and uses thereof in pharmaceutical compositions
11/29/2000EP1054880A1 TREATMENT OF MULTIPLE SCLEROSIS USING COP-1 AND Th2-ENHANCING CYTOKINES
11/29/2000EP1054691A1 Skin care compositions
11/29/2000EP1054686A1 Pharmaceutical formulation of a didemnin compound
11/29/2000EP1054685A1 Liquid crystal forms of cyclosporin
11/29/2000EP1054675A1 Regulation of estrus and ovulation in gilts
11/29/2000EP1054674A2 Oral liquid formulations of benzoxazinones hiv reverse transcriptase inhibitors
11/29/2000EP1054672A1 Morphine sulphate microgranules, method for making same and pharmaceutical preparations
11/29/2000EP1054671A1 New use for pain management
11/29/2000EP1054666A1 Liquid pharmaceutical formulation containing zotepine
11/29/2000EP1054662A1 Water-soluble eye drop
11/29/2000EP1054595A1 Methods and compounds for the genetic treatment of hyperlipidemia
1 ... 2434 2435 2436 2437 2438 2439 2440 2441 2442 2443 2444 2445 2446 2447 2448 2449 2450 2451 2452 2453 2454 ... 2991